This page presents the experimental results from our DBTL (Design-Build-Test-Learn) cycles for arsenic biosensor development. The results are organized into three modules covering basic circuit construction, promoter engineering, and system-level optimization.
This module focuses on the construction and initial optimization of basic arsenic-responsive circuits through three DBTL cycles, identifying core issues and eliminating interference factors.
Three recombinant plasmids were successfully assembled (pET46a-ArsR-sfGFP-V0, pET46a-PlacV-ArsR-ParsOC2-sfGFP-V1, pET46a-ParsOC2-ArsR-sfGFP-V2). Verification through restriction enzyme digestion, antibiotic resistance screening, colony PCR, and sequencing confirmed correct insertion of the elements (ArsR, sfGFP, and corresponding promoters) without sequence mutations or assembly errors.
Using a multi-gradient NaAsO₂ treatment (0-300 ppb, 0-300 μM), the "fluorescence value (Fluo)/cell density (OD600)" correction ratio was measured by a microplate reader, yielding key data:
Two optimized plasmids were successfully constructed (pET46a-PlacV-ArsR-ParsOC2-sfGFP-V3, pET-46a-PJ100-ArsR-ParsOC2-sfGFP-V4). Following C1's standardized molecular cloning workflow (restriction digestion, ligation, transformation, sequencing), it was confirmed that the ArsR coding sequence in V3 was optimally positioned, and the strong constitutive promoters (PJ100/PJ101/PJ102/PJ104/PJ111) was correctly inserted.
Using the same multi-gradient NaAsO₂ treatment and "Fluo/OD600" detection method as C1, the performance differences between V3, V4, and C1's V1, V2 were compared. Key data are as follows:
Regardless of adjustments to induction concentration, duration, or initial OD values, the arsenic-free background levels in V3 and V4 showed no significant reduction, completely ruling out "unreasonable induction conditions" as a confounding factor.
This module introduces the innovative "niche matching" strategy and develops novel promoter components with stronger compatibility through DBTL cycles.
ParsCML2 exhibits stronger co-evolutionary adaptation and lower binding free energy compared to the CML2-derived ArsR, significantly reducing GFP background leakage to 8% under arsenic-free conditions. At arsenic concentrations ranging from 50 to 300 μM, its fluorescence intensity reached 4785–6000 a.u., representing 2.3–3.1 times that of the ParsOC2 system, while maintaining stable performance in the rice paddy microenvironment (pH 6.2–6.8, microaeric conditions).
Currently, only library construction design and preliminary operations have been completed; screening and testing have not yet commenced.
This module integrates the innovative strategy of "AND-gate-like circuit" and attempts to solve the basal leakage problem from the "system level" through DBTL iteration.
The improved split-GFP variant system exhibits leakage efficiency below 1%, with negligible spontaneous background fluorescence in the absence of arsenic. It accurately distinguishes between "background signals" and "arsenic-induced signals" when detecting low arsenic concentrations, significantly enhancing detection specificity. However, a drawback is that fluorescence intensity increases slowly with rising arsenic concentrations (e.g., 200–300 μM), resulting in a relatively weak overall response signal.
Currently, plasmid structure design and preliminary construction have been completed. We purified the GFP1-10 (52.49 kDa) and the GFP11 (3.96kDa). Stability testing and fluorescence detection have not yet been conducted.
Through seven DBTL cycles organized into three modules, we have systematically addressed key challenges in arsenic biosensor development: